KATELYNN SCHUMACHER: Open Payments
NPI 1093579484 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,132 in 59 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $436 · 2025 $1,132
Food & beverage: $1,132
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $291 |
| Amgen Inc. | 7 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $105 |
| PFIZER INC. | 5 | $100 |
| Novo Nordisk Inc | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Corcept Therapeutics | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Exact Sciences Corporation | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
Products named: UBRELVY, CAPLYTA, Kerendia, Korlym, KRYSTEXXA, Wegovy, QULIPTA, MOUNJARO.
Industry payments across ID — which companies pay providers there.
